This phenotype mirrors the behavior of several angiogenesis-addicted cancers [120,121,122,123,124], in which laboratory and angiogenesis-markers [63,125] related to the VHL [91] and mTOR (mammalian target of rapamycin) pathway [92] are also shared. Here, MTOR is linked to cancer.